These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials. Bates D Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678 [TBL] [Abstract][Full Text] [Related]
7. Drug Insight: interferon treatment in multiple sclerosis. Marrie RA; Rudick RA Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519 [TBL] [Abstract][Full Text] [Related]
8. [Advances in the treatment of multiple sclerosis?]. Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968 [TBL] [Abstract][Full Text] [Related]
9. The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up. Reggio E; Nicoletti A; Fiorilla T; Politi G; Reggio A; Patti F J Neurol; 2005 Oct; 252(10):1255-61. PubMed ID: 15940386 [TBL] [Abstract][Full Text] [Related]
13. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
14. Management of multiple sclerosis: current trials and future options. Noseworthy JH Curr Opin Neurol; 2003 Jun; 16(3):289-97. PubMed ID: 12858064 [TBL] [Abstract][Full Text] [Related]
17. Established and novel disease-modifying treatments in multiple sclerosis. Cross AH; Naismith RT J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E; J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Wingerchuk DM; Carter JL Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135 [TBL] [Abstract][Full Text] [Related]
20. Current therapeutic recommendations in multiple sclerosis. Berger T J Neurol Sci; 2009 Dec; 287 Suppl 1():S37-45. PubMed ID: 20106347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]